How a non-invasive biomarker could help with earlier breast cancer metastatic diagnosis?
Every fourteen seconds, a woman
gets a breast cancer diagnosis somewhere in the world. Although treatments for
early-stage and non-metastatic breast cancer are now possible thanks to medical
advances, advanced stage and metastatic breast cancer is thought to be
incurable and has a very poor prognosis. Because early identification of breast
cancer metastasis is crucial to the condition's therapy, a group of researchers
has identified a non-invasive biomarker that may facilitate an earlier
diagnosis.
From the EVs of several
metastatic breast cancer cell lines, a collection of protein expression
profiles are gathered using an ultra-sensitive protein identification
technique. They found that integrins v and 1 were persistently overexpressed in
EVs with a strong metastatic background, among many other potential proteins.
Fundamental understandings of the underlying processes of breast cancer
metastasis have emerged as a result of the work. In addition to being
clinically applicable, the research increases the understanding of EVs by
revealing functionally different subgroups of EVs that are now easier to
identify and study in order to comprehend their roles and potential as
therapeutic targets in the context of tumour environments.
Comments
Post a Comment